Abstract:Object: Craniopharyngiomas (CPs) are histologically benign tumors, yet they may carry an unfavorable prognosis. "Giant" tumors are associated with worse prognosis. Our aim was to evaluate the impact of tumor's size on different short- and long-term clinical factors. Methods: Between 2002 and 2012, a total of 36 consecutive CP patients less than 18 years of age and with at least 12 months of post-operative follow-up (FU) underwent a total of 54 operations for excision of CPs. Gross total resection (GTR) was the goal for all the first surgical resections. Twenty-seven patients were identified as eligible for inclusion in this study. Data were retrospectively collected by reviewing pertinent clinic/office notes and inpatient records as well as pre- and post-operative imaging. Long-term neurosurgical, ophthalmological, and endocrinological outcomes were obtained from records of the most recent FU office visit. Statistical analysis was performed to compare data from patients with tumors greater than or equal to 4.5 cm (nine patients) to those with smaller ones (<4.5 cm; 18 patients). Results: Mean age at the time of surgery was 5.4 years (median 5 years, range 1.3-15.3 years) for patients in the large-tumor group (LTG) and 8.9 years (median 9.6 years, range 2.1-17.1 years) for the small-tumor group (STG). Average duration of follow-up was 82.1 and 105.4 months for LTG and STG patients, respectively. There was a noticeable difference in the rate of emergent surgeries between the two groups (33.3 vs. 5.5 % in the LTG and STG, respectively; p = 0.055) as well as in recurrent surgeries (RR = 3.76; CI = 95 %, 1.793-7.877) and radiotherapy (RR = 2, 95 % CI 0.775-5.154). Rates of residual tumor on both initial post-operative imaging and last FU imaging were significantly increased in LTG patients (44.5 vs. 27.7 % and 66.6 vs. 16.6 %; respectively). Progression-free survivals (PFS) assessed at 2 and 5 years were 33.3 vs. 73.3 % (RR = 2.2, 95 % CI = 0.171-1.202) and 33.3 vs. 53.3 % (RR = 1.6, 95 % CI 0.221-1.765) in favor of smaller tumors. No difference in 2-, 5-, and 10-year overall survival was found. We found no significant difference in mean BMI at last follow-up between the two groups (23.83 ± 4.86 and 27.33 ± 8.09, respectively; p = 0.27), although significantly more patients in the LTG had shorter stature (mean height SDS -1.72 ± 1.88 and -0.17 ± 1.08 in LTG and STG patients, respectively; p = 0.027). Conclusion: Tumor's size has significant impact on the management of CP in children. It affects both short-term factors (initial symptoms, urgency of surgical resection, extent of resection, and perioperative morbidity) as well as long-term parameters (PFS, rate of adjuvant treatments/recurrent surgeries, and metabolic/endocrinal/ophthalmological and functional outcomes). We think that a proper, world-wide accepted definition of what is "large," "giant," or even "monstrous" CP should be established. This will enable carrying multi-institutional studies on a larger group of patients, allowing further determining the importance of tumor's size in the management and outcome of craniopharyngiomas in children.

Growth and weight of children with craniopharyngiomas based on the tumour location and growth pattern.

Growth Patterns of Craniopharyngiomas: Clinical Analysis of 226 Patients.

Long-term weight gain in children with craniopharyngioma

The Impact Of The Site Of Origin And Rate Of Tumour Growth On Clinical Outcome In Children With Craniopharyngiomas

Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life

[Surgical Treatment of Childhood Craniopharyngioma: Clinical Analysis of 31 Cases].

Evaluating Eating Behaviour, Energy Homeostasis, and Obesity in Childhood-Onset Craniopharyngioma: A Feasibility Study

The Clinical Characteristics and Surgical Treatment of Infradiaphragmatic Craniopharyngioma in Children

Does subtotal resection ameliorate hypothalamic morbidity in pediatric craniopharyngioma? A 30-year retrospective cohort study

A Comparison of Long-Term Treatment Outcomes Between Giant and Nongiant Craniopharyngiomas

Consequences of craniopharyngioma surgery in children

Craniopharyngioma in children: trends from a third consecutive single-center cohort study

Giant craniopharyngiomas in children: short- and long-term implications

Analysis of Prognostic Factors, Extent of Resection, and Long-Term Outcome of Craniopharyngioma in Adults and Children

Risk Factors Associated with Postoperative Obesity in Childhood-Onset Craniopharyngioma Patients: a Case-Control Study.

Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases

Obesity in patients with craniopharyngioma in the South Asian region - A distinct phenotype

Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience

Influence of previous treatments on repeat surgery for recurrent craniopharyngiomas in children

Clinical Value of QST Classification in the Treatment of Children with Craniopharyngioma

The Characteristics and Surgical Treatments of Various Types of Craniopharyngiomas Classified by QST